Immunogenicity and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 Season Southern Hemisphere) in Adults 18 Years of Age and Above
Clinical trial NCT02369341 · COMPLETED
Trial details
- NCT number
- NCT02369341
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-29
- Primary completion
- 2015-06-03
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.